Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: once (1000)

Enhanced recovery after elective caesarean section - patient information

Description: This leaflet contains information about the recovery process after having a planned (elective) caesarean section.
Url: /Media/UHS-website-2019/Patientinformation/Pregnancyandbirth/Enhanced-recovery-after-elective-caesarean-section-1130-PIL.pdf

Nordic 3000

Description: Chemotherapy Protocol LYMPHOMA CYCLOPHOSPHAMIDE-CYTARABINE-DOXORUBICIN-PREDNISOLONE-RITUXIMABVINCRISTINE (Nordic 3000) Inpatient-Outpatient Regimen There a
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Nordic-3000.pdf

Nordic_2000

Description: Chemotherapy Protocol LYMPHOMA CYCLOPHOSPHAMIDE-CYTARABINE-DOXORUBICIN-PREDNISOLONE-RITUXIMABVINCRISTINE (Nordic 2000) Inpatient-Outpatient Regimen There a
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Nordic-2000.pdf

VAC31518COV2001_UK_Young Person_ Patient Information Sheet ICF_V2.0_15Feb2021_Clean Localised (3)

Description: Southampton NIHR Clinical Research Facility University Hospital Southampton NHS Foundation Trust
Url: /Media/Southampton-Clinical-Research/Downloads/VAC31518COV2001-UK-Young-Person-Patient-Information-Sheet-ICF-V2.0-15Feb2021-Clean-Localised-3.pdf

STHW841-V1-Biomerieux-Blood-culture-guidance

Description: BLOOD CULTURE A key investigation for diagnosis of bloodstream infections OUR SPECIAL THANKS GO TO Dr Susa
Url: /Media/SUHTExtranet/DepartmentOfInfection/STHW841-V1-Biomerieux-Blood-culture-guidance.pdf

jointtrainrev_08

Description: <!-- Hide from scriptless browsers snapAddEvent(window, 'load', snapInit); // Global settings var pageNumber=0; var lastPageNumber=0; var pBars=12; var hasSubmitted = false; var showButtons=true; var
Url: /suhtapps/Surveys/jointtrainrev_08.htm

portsmouth_hospitals_health_survey_08

Description: <!-- Hide from scriptless browsers snapAddEvent(window, 'load', snapInit); // Global settings var pageNumber=0; var lastPageNumber=0; var pBars=12; var hasSubmitted = false; var showButtons=true; var
Url: /suhtapps/Surveys/portsmouth_hospitals_health_survey_08.htm

Handling concerns and complaints policy

Description: Handling Complaints Policy, Version 13.0 Trust reference PET003 Version number 13.0 Description Policy to explain how Univ
Url: /Media/UHS-website-2019/Docs/Policies/Handling-concerns-and-complaints-policy.pdf

AmB - Cytarabine(1500)

Description: Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA AmB- CYTARABINE (1500mg/m2) Ambulatory Regimen This regimen is for AMBULATORY C
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/AmB-Cytarabine1500-Ver-1.pdf

AmB - Cytarabine(3000)

Description: Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA AmB- CYTARABINE (3000mg/m2) Ambulatory Regimen This regimen is for AMBULATORY C
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/AmB-Cytarabine-3000.pdf

81 to 90 of 1000

Previous … 7 8 9 10 11 … Next